Showing results (211-220 of 287) with videos related to

Sort By:
Pageof 29
Journal of Medicinal Chemistry|November 9, 2013
Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptorsSulan Luo, Dongting Zhangsun, Xiaopeng Zhu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 19, 2014
Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in miceSarah S Sanjakdar, Pretal P Maldoon, Michael J Marks, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 27, 2015
Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferentsJ Chris Holt, Kevin Kewin, Paivi M Jordan, et al.
ACS Chemical Neuroscience|June 30, 2023
DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-<i>b</i>]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric MechanismsHan-Shen Tae, Marcelo O Ortells, Bassel J Tekarli, et al.
Structure (London, England : 1993)|December 30, 2025
Shape-shifting conotoxins reveal divergent pore-targeting mechanisms in nicotinic receptorsBiddut Bhattacharjee, Colleen M Noviello, Md Mahfuzur Rahman, et al.
The Journal of Biological Chemistry|June 29, 2006
Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptorsTodd T Talley, Baldomero M Olivera, Kyou-Hoon Han, et al.
Molecular Pharmacology|April 16, 2003
Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in miceMaryka Quik, Jocelyn D Sum, Paul Whiteaker, et al.
Neuropharmacology|July 1, 2019
α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptorsMarloes van Hout, Amanda Valdes, Sean B Christensen, et al.
Biochemical Pharmacology|March 30, 2010
Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine releaseAndrew M Smith, Marharyta Pivavarchyk, Thomas E Wooters, et al.
Neuroscience Letters|November 16, 2004
Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatumMelissa Ray, Iwo Bohr, J Michael McIntosh, et al.
Pageof 29